BIOPROTECTION SYSTEMS CORPORATION
Live attenuated vaccine for Rift Valley Fever Virus
- Sector
- Biotech
- Headquarters
- AMES, IA
- Founded
- 2005
- Latest Form D
- $2.5M, Jul 2010
- Total capital
- $19M
- Federal grants
- $90K
- 2 awards · 2011
- Rank in peer group#22 of 1449
- Private capital raised
- $3M
- 3 Form D · last Jul 2010
- 195 months since last filing
- Federal contracts
- $15.9M
- 5 awards · Defense
- Rank in Biotech#47 of 4373
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Federal contractDefense · Igf::ot::igf Base Period$1.6M
- Federal contractDefense · Igf::ot::igf Undefinitized Contract Action. Development Of A Countermeasure Against The Ebola Virus$6.4M
- Federal grantAgriculture · Development Of A Safe And Efficacious Vaccine For Rift Valley Fever Virus$100K
- Private capital raisedForm D · SEC · 3rd filing$2.5M
- Private capital raisedForm D · SEC · 2nd filing$363K
- Private capital raisedForm D · SEC · 1st filing$124K
- Federal contractDefense · Research And Development Base Award$7M
Show 2 earlier federal awards
- Federal contractDefense · Scientific Research Services$734K
- Federal contractDefense · Basic Contract Award$100K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Federal first
24months
from BIOPROTECTION SYSTEMS CORPORATION’s first federal award to its first private round.
- First federal award · May 2008
- Defense · $100K
- First Form D · Apr 2010
- $124K · 1st Form D
- Awards before first raise
- 3 awards
An association in public records, not a cause or a prediction.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Federal grants#22 · top 2%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Carl LangrenExecutive OfficerNamed in SEC Form D filings
- Charles LinkExecutive Officer, DirectorNamed in SEC Form D filings
- Ernie TalaricoDirectorNamed in SEC Form D filings
- Joseph LucasExecutive OfficerNamed in SEC Form D filings
- Nick VahanianExecutive OfficerNamed in SEC Form D filings
- Ramon FlickExecutive OfficerNamed in SEC Form D filings
Show all 8 people
- Steve StahlyDirectorNamed in SEC Form D filings
- Thomas RaffinDirectorNamed in SEC Form D filings
What it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- Arteriocyte, Inc.Similar federal contract value in Biotech · $18.7M in contracts
- PTC TherapeuticsSimilar federal contract value in Biotech · $18.6M in contracts
- TALPHERA, INC.Similar federal contract value in Biotech · $17M in contracts
- REPLIGEN CORPSimilar federal contract value in Biotech · $14.9M in contracts
- AUTOIMMUNE TECHNOLOGIES, LLCSimilar federal contract value in Biotech · $14.8M in contracts
- BLUEWILLOW BIOLOGICS INCSimilar federal contract value in Biotech · $14.7M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .